Cardium Therapeutics, Inc. (CXM) Builds a Diverse Approach to the Medical and Health Marketplace
Cardium Therapeutics is implementing a broad-based strategy of engaging the medical and health marketplace, focused on opportunities offering a clear path to monetization. Generx, Cardium’s lead clinical development product candidate, is unique in its ability to stimulate the growth of blood vessels in the heart for patients with insufficient blood flow as the result of cardiovascular disease. Instead of invasive and terribly expensive operations such as coronary angioplasty or bypass surgery, or taking traditional anti-anginal drugs that simply treat the pain, Cardium’s Generx product candidate offers a potential non-surgical and less expensive therapeutic option. This is of special importance in…